Palo Alto Ketamine Therapy For Treatment-Resistant Depression Expanded

Recent industry research shows that depression is the most common mental struggle in the US, and is strongly linked to suicidal behavior. Soft Reboot Wellness explains that as 21 million adults experience major depression each year, its latest move is intended to provide fast-acting relief.

A case study showing how ketamine infusions have helped a person suffering from mid-life crisis and other depression symptoms can be found here:

With 30% of individuals who take medication finding that they only partially relieve depression symptoms, ketamine therapy is gaining traction as an alternative to traditional approaches. The recent therapy expansion from Soft Reboot Wellness is expected to improve access to this innovative treatment.

Ketamine therapy involves the use of low doses of the drug Ketamine, an anesthetic that has been used safely for decades. Now studies have found that it can be effective in treating depression, particularly in those who have not responded to traditional approaches.

Recent studies have shown that up to 70% of patients with treatment-resistant depression (TRD) experienced a significant reduction in depressive symptoms within 24 hours of receiving ketamine therapy. This rapid improvement can provide much-needed relief to those who have been struggling with the condition for years.

Ketamine has also been shown to increase the levels of a protein called brain-derived neurotrophic factor (BDNF), which is essential for the growth and maintenance of neurons in the brain. By increasing BDNF levels, ketamine may help to alleviate symptoms of this mental health struggle, which is a promising avenue of research that could lead to new treatments for depression in the future, according to the clinic.

Additional details are provided at

Soft Reboot Wellness explains that the early clinical results for ketamine therapy are encouraging, and many mental health professionals are optimistic about the potential it offers to provide relief to those who have been suffering from TRD. Studies have also shown that it is a well-tolerated drug and has a low risk of side effects.

A spokesperson states: “Ketamine was first introduced as an anesthetic in 1970 and has been used safely in medical procedures for over 50 years. It was more recently that researchers discovered that ketamine could be used to treat depression. The benefits of ketamine therapy have been demonstrated in a number of clinical trials.”

Interested parties can learn more at

Soft Reboot Wellness

825 Oak Grove Ave
# A101
United States

comtex tracking